{
    "55046d5ff8aee20f27000007": "single-molecule pull-down",
    "553fa78b1d53b76422000007": "MEG3",
    "5149199dd24251bc05000040": "acetylcholinesterase inhibitors",
    "5709e4b2cf1c32585100001c": "Nlk2",
    "53061af558348c0f52000002": "Cell-Cycle Arrest",
    "53137541e3eabad021000010": "Reprogramming",
    "5718bbb37de986d80d00000b": "ataxia-neuropathy syndrome",
    "52bf202003868f1b06000018": "epilepsy",
    "56be0da3ef6e394741000007": "thrombocytopenia",
    "56a92be0a17756b72f000009": "ccna1",
    "56c3327c50c68dd41600000c": "negative DNA superhelicity",
    "5314a7a4dae131f847000003": "mutations in sarcomere proteins.",
    "56c6dd275795f9a73e000008": "tri-methylation of lysine 9 on histone H3 (H3K9me3",
    "5322d9339b2d7acc7e000011": "c-KIT levels",
    "56c1f005ef6e39474100003a": "interleukin-13",
    "513ce3c8bee46bd34c000008": "CDC45",
    "56d06e043975bb303a000011": "Acute Lymphoblastic Leukemia",
    "571e1e11bb137a4b0c000004": "Valproate intoxication",
    "56a3a386496b62f23f000007": "JASPAR 2020",
    "571529efcb4ef8864c000001": "penicillin",
    "52b2d405f828ad283c000009": "Fibroblast-like synoviocytes",
    "552faa43bc4f83e828000004": "BCL11B",
    "533c3af6c45e13371400000d": "CYLD cutaneous syndrome",
    "571f3b320fd6f91b68000007": "Adrenocorticotropic hormone",
    "54d65b6b3706e8952800000c": "PMP22",
    "517a8c918ed59a060a000043": "Polymer",
    "571f2b5bbb137a4b0c000010": "CCM2",
    "511a4d391159fa8212000003": "Single-stranded DNA (ssDNA) plant viruses",
    "517137c18ed59a060a000001": "CDYL2",
    "531d7430267d7dd053000008": "psychotropic drugs",
    "52df8ce798d023950500000d": "cocoa flavanols",
    "5505b9ff8e1671127b000001": "Atg7",
    "57090784cf1c325851000011": "Weaver syndrome",
    "56ebfa13107309bc2f000004": "higher order chromatin folding",
    "533c2230c45e133714000002": "tumour suppression",
    "514241fcd24251bc05000006": "SFPQ",
    "531376c8e3eabad021000012": "phospholamban (PLN",
    "5312280ce3eabad02100000a": "8",
    "532ad23ad6d3ac6a34000011": "N2",
    "5156be75d24251bc05000088": "ischemic cerebrovascular disease",
    "57169b63cb4ef8864c00000b": "excitatory amino acid transporter 5",
    "55391ce8bc4f83e828000018": "RAS",
    "51542dc3d24251bc0500007e": "toxic epidermal necrolysis",
    "51595fb0d24251bc0500009c": "Phgdh",
    "5547d700f35db75526000007": "Childhood Dysarthria",
    "531b1e3cb166e2b80600003b": "H3K27me3",
    "56bb616dac7ad10019000008": "Rivaroxaban",
    "56b3a3ce8525abca1e000005": "indirect immunofluorescent detection of lipid droplet-associated proteins",
    "535d59349a4572de6f000009": "iron deficiency",
    "5713bf261174fb1755000011": "micro-fluid channel networks complex three-dimensional tissue structures",
    "5309f8f5970c65fa6b000001": "KRAS",
    "56d1d94667f0cb3d66000005": "development",
    "56d29d4df22319765a000003": "metabolomics",
    "5318367cb166e2b806000012": "DJ-1",
    "515d1ff7298dcd4e51000009": "cancer cell killing system that kills the cancer cells",
    "56ed27202ac5ed145900000c": "Osteosarcoma",
    "530cf4e0c8a0b4a00c000004": "troponin T",
    "530cf4e0c8a0b4a00c000005": "fibrillin 1",
    "5518e817622b194345000006": "VPS35",
    "5319abe4b166e2b80600002e": "SNAI1",
    "54ff30dc6ad7dcbc1200000f": "diseases",
    "55031628e9bde69634000024": "cervical small-cell carcinoma",
    "54d670163706e8952800000f": "IRX",
    "5324cf139b2d7acc7e00001f": "bupropion",
    "56be0a18ef6e394741000006": "pleural effusion",
    "5311b99ae3eabad021000004": "blood urea nitrogen",
    "5131fa145274a5fb07000009": "Chorioangiomas",
    "5505eed08e1671127b000006": "trypsin",
    "54e1252fae9738404b000003": "classification",
    "517a8bef8ed59a060a000041": "iodothyronine deiodinase (Dlk1-Dio3",
    "5148885ad24251bc05000032": "VKORC1 and CYP2C9",
    "571e189dbb137a4b0c000003": "acute kidney injury",
    "52bf1f4503868f1b06000016": "deep venous thrombosis",
    "52eeddfcc8da898910000010": "periodic paralysis",
    "56f56a8609dd18d46b00000b": "ABCA12",
    "532c0c21d6d3ac6a3400001b": "three-dimensional molecular alignment",
    "5166f41a298dcd4e5100005b": "SAHA",
    "517539af8ed59a060a000026": "PGC-1\u03b1",
    "52d2818403868f1b06000033": "Kymriah",
    "571cd9537de986d80d00000e": "gasdermin D reveals a region recognized by inflammatory caspase-11",
    "553d061cf321868558000013": "OncoBase",
    "56c1f043ef6e394741000057": "MT2 receptors shall lead to the development of highly selective melatonin receptor agonists.Selective melatonin receptor",
    "5318380bb166e2b806000013": "RBR family",
    "5173b5ea8ed59a060a00001f": "HDACs",
    "5324cca79b2d7acc7e00001d": "Otolaryngology",
    "54f431d664850a5854000006": "NPM1",
    "570a5343cf1c325851000022": "Val60Leu",
    "5141bcd423fec9037500000d": "Navarixin",
    "52bf1af803868f1b06000008": "catecholaminergic polymorphic ventricular tachycardia",
    "550303a5e9bde6963400000c": "Seasonal Allergic Rhinitis",
    "51bdf045047fa84d1d000003": "Atg4",
    "515db020298dcd4e51000011": "randomized controlled trial",
    "56c1f007ef6e39474100003b": "fractionated scheme",
    "56e46ad951531f7e3300001a": "Hedgehog",
    "56cf2be73975bb303a000005": "anti-IL-5 monoclonal antibodies",
    "5713bc991174fb1755000010": "immunoglobulin mu-binding protein 2 (IGHMBP2",
    "515de993298dcd4e51000024": "tics",
    "54fc9b236ad7dcbc12000005": "Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives.Therefore, in the past decades,",
    "54fe09036ad7dcbc12000009": "fish fillet",
    "517295c18ed59a060a000016": "MicroRNAs",
    "5505c9008e1671127b000002": "RICTOR and SIN1",
    "5326c6fed6d3ac6a3400000c": "abdominal obesity",
    "5319a6c9b166e2b806000022": "small molecule inhibitors",
    "56a37e33496b62f23f000003": "triplets",
    "571ce13f7de986d80d000011": "chorioamniotic membranes",
    "533c3533c45e133714000004": "miR-223",
    "52f112bb2059c6d71c000002": "m7G) is present at mRNA caps",
    "5358e067f1005d6b5800000b": "Drebrin",
    "52f893f92059c6d71c00003c": "drugs aiming at the treatment of sarcopenia in older adults.",
    "56f96333cf1c325851000004": "hydrogen bonds",
    "54c90dabf693c3b16b000004": "sarcoplasmic reticulum calcium-ATPase",
    "52f8995b2059c6d71c00004a": "BTBD9",
    "52bf1dea03868f1b06000012": "sedation or anhedonia",
    "530cf4d5e2bfff940c000004": "protein-protein interaction",
    "55439140ed966d112c00000a": "phycobiliproteins (PBPs",
    "554143ad182542114d000004": "consensus methods",
    "5319abffb166e2b80600002f": "transforming growth factor \u03b21",
    "5171651e8ed59a060a000009": "prostate cancer",
    "55414c65472cfd8617000001": "MLBioMedLAT",
    "530e1c985937551c09000004": "coronary syndromes",
    "5713b0a51174fb175500000e": "nonsyndromic sensorineural deafness",
    "56c8605b5795f9a73e000014": "Janus kinase (JAK)1/JAK2",
    "550b0408c2af5d5b7000000c": "shell",
    "53188992b166e2b806000019": "2",
    "52ebb2c698d0239505000029": "Pulmonary lymphangioleiomyomatosis",
    "57220e400fd6f91b68000015": "Thymic Small Cell Carcinoma",
    "5162c8a8298dcd4e51000047": "PDE12",
    "56a3bf0f496b62f23f00000a": "CNVRanger",
    "56c3326750c68dd41600000b": "H2B",
    "534df8c9aeec6fbd07000016": "autoimmune diseases",
    "56e30dd551531f7e33000016": "clock",
    "52e6c92598d0239505000019": "deltaE50-MD dog model of DMD",
    "531778ddb166e2b80600000f": "239 patients diagnosed before 46 years and without Chompret criteria for LFS",
    "52fb42752059c6d71c00005e": "4,4'-methylenediphenol",
    "5509b6d22e93f0133a000005": "minimally invasive surgery",
    "56be0e4aef6e394741000008": "bronchiectasis, and situs inversus",
    "54dfc6501388e8454a000009": "antiviral and proliferative",
    "52e0c9a298d0239505000010": "H3K9me2",
    "51487ef9d24251bc05000031": "Opicapone",
    "5505db6a8e1671127b000003": "desmosoma",
    "54c225bcf693c3b16b000002": "CASQ2",
    "532c0d7fd6d3ac6a3400001c": "Flexi-pharma",
    "530c844e970c65fa6b000014": "Mitochondrial neuro-gastro-intestinal encephalomyopathy",
    "571653aecb4ef8864c000005": "gefitinib",
    "517a8bab8ed59a060a000040": "deiodinase",
    "56c33e5695c1e7cc5b000001": "nuclear envelope",
    "570921e4cf1c325851000017": "promoter region",
    "56bcc455d36b5da378000003": "Myelofibrosis",
    "52f89fd32059c6d71c000051": "LSD1 and MYEF2",
    "551829a76487737b43000009": "tuberculosis",
    "52bf209303868f1b0600001a": "myocardial infarction",
    "55152bd246478f2f2c000002": "DG",
    "516c3960298dcd4e51000073": "DNMT1",
    "54e0ac041388e8454a00000f": "L1",
    "55192f20622b194345000014": "dimers",
    "52fa73e82059c6d71c000059": "In utero electroporation",
    "551910d3622b194345000008": "NRTN",
    "52fb78d82059c6d71c000068": "C5607T",
    "55031270e9bde6963400001a": "hypocellular",
    "56d2ac03f22319765a000004": "ESBL isolates.",
    "51716a438ed59a060a00000a": "Comparative analysis",
    "53215fca9b2d7acc7e000005": "MICOS",
    "56ae40110a360a5e45000009": "CS-Rosetta",
    "52f509232059c6d71c00001f": "KCNQ1",
    "56be1723ef6e39474100000c": "headache",
    "516ec97f298dcd4e51000087": "phylogeny reconstruction",
    "54fc9ca16ad7dcbc12000006": "orexin",
    "56c1f030ef6e39474100004d": "neonatal diabetes mellitus",
    "550312b4e9bde6963400001c": "RPL35A",
    "54edaee3445c3b5a5f000003": "Borrelia miyamotoi",
    "5335d4e8d6d3ac6a34000053": "ETB",
    "518ba4b5310faafe08000005": "corticosteroids",
    "56f8077a8b98c98849000002": "small-cell lung cancer",
    "5503145ee9bde69634000022": "medullary thyroid cancer",
    "5333f728d6d3ac6a34000041": "protein-protein interaction",
    "51601071298dcd4e51000038": "recombinant protein",
    "515993f3d24251bc050000a0": "antibodies",
    "53357c98d6d3ac6a3400004a": "predisposition to cancer of other types.This study investigates the utility of a custom-designed multi-gene panel",
    "5523e47f7b523f2123000004": "green fluorescent protein",
    "54fb5720d176fff445000002": "Klf4",
    "5363bad27d100faa0900000e": "RNA",
    "5720a8da0fd6f91b68000010": "narcolepsy",
    "54d8d60d014675820d000007": "V600R",
    "531375a6e3eabad021000011": "syncope",
    "56d1e23c67f0cb3d66000009": "TAZ",
    "531b3ff3b166e2b80600003d": "E-cadherin",
    "52f5417b2059c6d71c000024": "Pten",
    "5717ab7ccb4ef8864c00000c": "mitophagy",
    "530a3e18970c65fa6b000005": "Leifsonia",
    "570a922dcf1c325851000028": "necroptosis",
    "51bdb644047fa84d1d000001": "PNET1",
    "534ab91eaeec6fbd07000012": "RGS2",
    "51740da48ed59a060a000024": "ExPasy ProtParam",
    "552435602c8b63434a000009": "retinoblastoma protein",
    "54f21b69c409818c32000007": "Hemochromatosis type 4",
    "52e203bc98d0239505000011": "TEBPs",
    "56be2570ef6e39474100000d": "Neuroticism",
    "56c1f000ef6e394741000037": "fluoropyrimidine (trifluridine",
    "54cf6d40f693c3b16b00000e": "aspirin",
    "530cf4fe960c95ad0c000007": "ischemic heart failure",
    "5539029cbc4f83e828000012": "DDX3X",
    "5300aad02059c6d71c000080": "football, cricket, and rugby",
    "56c1f034ef6e394741000050": "parkinsonism",
    "516e5f25298dcd4e5100007d": "Methotrexate",
    "52fc8b772059c6d71c00006e": "inhibitors",
    "5324d0429b2d7acc7e000023": "androgenetic alopecia",
    "52ee065d98d0239505000033": "treatment",
    "56d094f33975bb303a000012": "cell division",
    "56acc7ca0a360a5e45000002": "web-based genome browsers",
    "5321badd9b2d7acc7e00000a": "melanoma",
    "56cdf3745795f9a73e000039": "RHEB-mTOR",
    "5508685b4b2a315d4100000a": "Inflammatory bowel disease",
    "52bf1d6003868f1b0600000e": "craniosynostosis",
    "553f96191d53b76422000004": "autophagic vacuole formation",
    "5306158358348c0f52000001": "deletions",
    "514a11add24251bc05000054": "recurrence score",
    "5165932e298dcd4e51000059": "methyltransferase inhibitors",
    "5131bef65274a5fb07000008": "histone marks",
    "5160412d298dcd4e5100003c": "H3K37",
    "551adceb622b194345000018": "transient ischaemic attack",
    "532f0b2cd6d3ac6a3400002c": "eyes",
    "5512c1ee6a8cde6b72000009": "MKK6",
    "515db70c298dcd4e51000017": "bacterial bronchitis",
    "54fb5c69d176fff445000003": "Mef2C, Tbx5",
    "513f45abbee46bd34c000013": "pancreatic",
    "56ddbbaf51531f7e33000009": "dimethylation of H3 Lys4",
    "517843638ed59a060a000036": "Long interspersed element class 1",
    "55031286e9bde6963400001b": "congenital erythroid aplasia",
    "533ec7abc45e133714000015": "M1BP",
    "54ecb640445c3b5a5f000001": "cytopenia",
    "513f3d1fbee46bd34c000010": "hypothyroidism",
    "553f7a71ab98a37113000009": "homologous recombination",
    "53355befd6d3ac6a34000046": "MDockPeP, HPEPDOCK",
    "52f89f4f2059c6d71c00004e": "NBEAL2",
    "550712739d0faaa527000008": "ryanodine receptor",
    "511a20f3df1ebcce7d00000c": "Psychosis",
    "518cca6f310faafe0800000a": "IGF1/PI3K/AKT",
    "56df03c751531f7e3300000a": "stability",
    "517775c78ed59a060a000033": "rapamycin",
    "517539e68ed59a060a000028": "MO25",
    "518cb5ab310faafe08000008": "levofloxacin",
    "54db7217c4c6ce8e1d000003": "RYR2",
    "532c0ac4d6d3ac6a3400001a": "docking calculations",
    "52e7b7cb98d023950500001c": "anti-diabetic",
    "58a7fb2860087bc10a000034": "ASH1L",
    "58846be0e56acf5176000005": "high-intensity focused ultrasound thalamotomy",
    "58919aad621ea6ff7e00000d": "2-chlorophenol by enrichment cultures under denitrifying conditions.",
    "587d2700fe8a08052f000001": "H3K27ac samples",
    "58a2efec60087bc10a000008": "subcellular relocalization",
    "58a0da5278275d0c4a000054": "cutaneous lupus erythematosus",
    "589a246378275d0c4a00002c": "Middle East Respiratory Syndrome",
    "58a326da60087bc10a00000e": "antiobesity drugs",
    "589aec4778275d0c4a000037": "bacterial",
    "58a0c09778275d0c4a000052": "linagliptin",
    "5884fe4ce56acf5176000010": "breast cancer",
    "58a3275960087bc10a00000f": "reproductive effects",
    "58a94483ee23e0236b000003": "type V",
    "58bc666702b8c60953000004": "degradation",
    "58bbb71f22d3005309000016": "RNA CoSSMos",
    "58bc9a5002b8c60953000008": "Innate and Adaptive Immune Responses",
    "58bbbe6822d300530900001a": "valine",
    "58b53bf722d3005309000004": "facial palsy",
    "58a8071760087bc10a000037": "electron capture dissociation",
    "588f220e3b87a8a73800000d": "RNase R",
    "589a245878275d0c4a000025": "grade",
    "58ca746d02b8c6095300002d": "mice",
    "588f952994c1512c50000007": "septo-optic dysplasia",
    "58c66a4b02b8c60953000025": "neurobehavioral disorders",
    "58bfcb8702b8c60953000016": "lichen planus",
    "58c6a6c502b8c60953000027": "vertigo",
    "58ce5c7c1f5fb2b734000001": "structure-activity relationships",
    "58c99acf02b8c60953000028": "subscapularis",
    "58cd59cb02b8c60953000039": "dengue",
    "58b548d722d3005309000005": "Corynebacterium diphtheriae",
    "58cea0768acda34529000001": "Tay-Sachs disease",
    "58c1b2f702b8c6095300001e": "antidepressant",
    "587d2b7efe8a08052f000003": "33",
    "58dfd83a6fddd3e83e000003": "Pnpla3",
    "58c6665602b8c60953000024": "toxoplasmosis",
    "58d8e9bd8acda3452900000b": "heart failure, arrhythmias and sudden cardiac death",
    "5880b2a6c872c95565000004": "JAK-STAT-pathway",
    "58e0035f6fddd3e83e000009": "slit diaphragm",
    "5880b583c872c95565000005": "Deintensification",
    "58add7699ef3c34033000009": "CPSF",
    "587d30fb31b33e8760000001": "chaos",
    "58a6c94860087bc10a00002a": "H3K27M",
    "58da14178acda34529000011": "rob(13;14",
    "58ea59273e8b6dc87c000012": "Viral",
    "5895b7157d9090f353000009": "microcephaly",
    "58f4b73b70f9fc6f0f000014": "rubella",
    "5895bfdc7d9090f35300000c": "primary adrenal insufficiency",
    "58dbb3f18acda34529000019": "monoclonal antibodies",
    "5895e4637d9090f353000012": "SAPHO syndrome",
    "5a6d0b2db750ff445500002d": "mitosis",
    "5a894f6abc7bade53a000004": "oxidative stress",
    "5a76196faacfb9cd4c000001": "immune thrombocytopenic purpura",
    "5a82fc89faa1ab7d2e000028": "H2A.Z-rich\u00a0+1",
    "5a882b5761bb38fb24000013": "type I interferonopathies",
    "5a43b2d7966455904c00000c": "inductive matrix completion",
    "590c740d70f9fc6f0f00001d": "STARD1",
    "5a67afb7b750ff445500000d": "electrophysiological features of POEMS syndrome to distinguish from CIDP",
    "5a678d63b750ff4455000003": "hormones",
    "5a70dbe599e2c3af26000004": "SMAD4",
    "5a70ce4ab750ff4455000064": "WNT1",
    "5a736efc3b9d13c708000006": "11",
    "5a8a9abdfcd1d6a10c000019": "DIAP2, IMD",
    "5a7723b79e632bc06600000b": "deflazacort",
    "5a7727f39e632bc06600000d": "inflammation",
    "5a86f074faa1ab7d2e00003a": "renal medullary carcinoma",
    "5a75fbf383b0d9ea6600000a": "Tofacitinib, a pan-JAK inhibitor,",
    "5a76155c83b0d9ea6600001e": "tofacitinib",
    "5a89a20ffcd1d6a10c00000e": "transforming growth factor-\u03b2",
    "5a86ebf2faa1ab7d2e000038": "clock",
    "5a7600b983b0d9ea6600000c": "Oral Psoriatic Arthritis triaL",
    "5a7244aa2dc08e987e00000f": "interleukin 12",
    "5a8842a261bb38fb24000015": "tumour destruction",
    "5a86c938faa1ab7d2e000034": "ETTIN",
    "5a76018c83b0d9ea6600000e": "thoracopagus",
    "5a7636d39e632bc066000004": "maftools",
    "5a981e66fcd1d6a10c00002f": "hyper-low density lipoproteinaemia",
    "5a8861eb8cb19eca6b000001": "gap detection",
    "5a68fd01b750ff445500001b": "integrative literature review",
    "5a6f7e6ab750ff4455000052": "beneficence, justice and autonomy or individual freedom",
    "5a70d12899e2c3af26000001": "uveitis",
    "5a8dc6b4fcd1d6a10c000026": "infliximab",
    "5a75dff883b0d9ea66000003": "manually",
    "5a75df9883b0d9ea66000002": "gastric stromal sarcomas",
    "5a981bcffcd1d6a10c00002d": "lactic acidosis",
    "5a7240aa2dc08e987e00000d": "Fully",
    "5aa80873d6d6b54f79000013": "Rpl22",
    "5aacdcf1fcf4565872000009": "protein partners of BET proteins have been described",
    "5aa55b65d6d6b54f7900000e": "Izumi fever",
    "5a736f0c3b9d13c708000007": "iron",
    "5aa13fd3d6d6b54f79000003": "buprenorphine/naloxone",
    "5aa82388fcf4565872000001": "NFE2L2/NRF2 is a transcription factor and master regulator of cellular antioxidant response",
    "5a9d96564e03427e73000001": "disease-modifying therapies",
    "5a9d2dd21d1251d03b00001a": "V3-glycan regions of the HIV-1 envelope glycoprotein",
    "5ac721230340b9f058000005": "EpCAM",
    "5ace20fa0340b9f05800000c": "CYP4F2",
    "5abd2ce0fcf456587200002a": "Bacteroidetes",
    "5aac5469fcf4565872000005": "Perinatal Yellow Fever",
    "5a7d5580faa1ab7d2e00001a": "imaging",
    "5ac2776195d0062724000006": "celiac disease",
    "5abd44b1fcf4565872000030": "MCFAs",
    "5ace34eb0340b9f058000010": "intraepidermal",
    "5aae6a86fcf456587200000e": "ultraviolet A",
    "5aaef38dfcf456587200000f": "obstructive sleep apnea",
    "5abce6acfcf4565872000022": "simvastatin",
    "5c34ad63da8336e21a000007": "non-essential genes",
    "5ad4eddf133db5eb78000009": "GPS-Prot",
    "5c34a029da8336e21a000003": "autoimmune disease of uncertain etiology that affects multiple tissues",
    "5be94f3d133db5eb78000022": "hepatocellular carcinoma",
    "5c34a761da8336e21a000005": "immune cell metabolism",
    "5be44d8b133db5eb78000015": "Bifidobacterium",
    "5c0e82b2133db5eb7800002d": "CD8 Cellular senescence",
    "5c61f379e842deac67000006": "c.1482delinsGCCAGG",
    "5c53131e7e3cb0e231000012": "clinical symptoms",
    "5c5315727e3cb0e231000014": "MERTK",
    "5c658a8f7c78d69471000007": "ivosidenib",
    "5c76c1457c78d694710000a6": "inflammatory bowel disease",
    "5c6c46677c78d69471000035": "limma",
    "5c76e6d27c78d694710000ac": "acridine orange",
    "5c5214207e3cb0e231000003": "Large-scale investigation of the reasons why potentially important genes are ignored",
    "5c7ab080d774d0424000000b": "cyclic GMP-AMP (cGAMP",
    "5c6e01af7c78d69471000048": "Antiviral drugs including maribavir",
    "5c6b7daa7c78d6947100002b": "telangiectasias",
    "5c56bbb107647bbc4b000011": "standard (ST) mutation mentions",
    "5c6f107c7c78d69471000051": "FAK",
    "5c6ffa257c78d69471000056": "autosomal recessive",
    "5c78174b7c78d694710000b1": "Bolt",
    "5c62a276e842deac6700000a": "TNFAIP3",
    "5c72fb4a7c78d69471000082": "achalasia",
    "5c8d00980101eac870000006": "Arboviruses",
    "5c8d0a980101eac870000008": "p16INK4a",
    "5c5f0f581a4c55d80b000012": "peripheral blood",
    "5c851a8175a4a5d219000005": "cytotoxin",
    "5c7d520ed774d0424000000f": "Diabetes",
    "5c73ace67c78d69471000083": "blepharophimosis",
    "5c6d783e7c78d6947100003a": "in\u00a0Toxins\u00a0[3].[...",
    "5c851c2675a4a5d219000006": "bezlotoxumab",
    "5c8bfe25d558e5f23200000f": "calcium ionophore-induced acrosome reaction",
    "5c900983ecadf2e73f000002": "givosiran",
    "5c6bda9d7c78d69471000031": "manually curated repositories",
    "5c6c497d7c78d69471000036": "tools",
    "5c88550075a4a5d219000008": "L-5F",
    "5ca60a77ecadf2e73f00004d": "biochar",
    "5c8c095e0101eac870000002": "adipose derived stem cells",
    "5c9d18f1ecadf2e73f000033": "anti-inflammatory",
    "5c961603ecadf2e73f000022": "Membranous Nephropathy",
    "5c979ffcecadf2e73f000028": "ocular toxocariasis (OT), or visceral larva",
    "5c97f579ecadf2e73f00002a": "neuroendocrine cells",
    "5c9fb583ecadf2e73f000042": "disease",
    "5ca9f932ecadf2e73f000054": "ROBO1",
    "5ca64b5becadf2e73f000051": "moesin",
    "5c9007460101eac870000012": "actin",
    "5c990afbecadf2e73f000030": "Mdm2 and MdmX",
    "5c961281ecadf2e73f000021": "rheumatoid arthritis"
}
